SMTL ID : 2oay.1

Crystal structure of latent human C1-inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.35 Å

Oligo State

monomer

Ligands

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 1 residues within 4Å: Chain A: N.128 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.128, A:R.131

3 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 4 residues within 4Å: Chain A: H.224, F.225, I.226, K.233 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:H.224, A:F.225 GOL.3: 4 residues within 4Å: Chain A: K.163, K.292, V.336, E.338 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:K.163, A:K.163, A:K.292, A:E.338 GOL.4: 4 residues within 4Å: Chain A: R.123, D.124, T.125, E.322 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.123, A:D.124, A:E.322

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Beinrohr, L. et al., C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease. J.Biol.Chem. (2007)

Release Date

2007-05-01

Peptides

Plasma protease C1 inhibitor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Plasma protease C1 inhibitor